Healthcare >> CEO Interviews >> July 5, 2004
JULIA P. GREGORY has been Executive Vice President, Corporate
Development and Chief Financial Officer of Lexicon Genetics since August
2003 and served as Executive Vice President and Chief Financial Officer
from February 2000 until August 2003. From 1998 to February 2000, Ms.
Gregory served as the Head of Investment Banking for Punk, Ziegel &
Company, a specialty investment banking firm focusing on technology and
health care and, from 1996 to February 2000, as the Head of the firm's
Life Sciences practice. From 1980 to 1996, Ms. Gregory was an investment
banker, primarily with Dillon, Read & Co., Inc., where she represented
life sciences companies beginning in 1986. Ms. Gregory is a member of
the Board of Directors and the Scientific Advisory Board of the Estee
Lauder Foundation's Institute for the Study of Aging, Inc., and a member
of The International Council for George Washington University's Elliott
School of International Affairs. She received her BA in International
Affairs from George Washington University and her MBA from the Wharton
School of the University of Pennsylvania. Profile
operations and technology.
Ms. Gregory: Lexicon Genetics is a drug discovery company using gene
knockout technology to
